Found: 15
Select item for more details and to access through your institution.
Surfactant protein D is a biomarker of influenza‐related pediatric lung injury.
- Published in:
- Pediatric Pulmonology, 2022, v. 57, n. 2, p. 519, doi. 10.1002/ppul.25776
- By:
- Publication type:
- Article
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Monoclonal Antibody MHAA4549A in Patients With Acute Uncomplicated Influenza A Infection.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 2, p. 1, doi. 10.1093/ofid/ofab630
- By:
- Publication type:
- Article
Early Amplified Respiratory Bioactive Lipid Response Is Associated With Worse Outcomes in Pediatric Influenza-Related Respiratory Failure.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 5, p. 1, doi. 10.1093/ofid/ofaa122
- By:
- Publication type:
- Article
Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Targeted depletion of lymphotoxin-α–expressing T<sub>H</sub>1 and T<sub>H</sub>17 cells inhibits autoimmune disease.
- Published in:
- Nature Medicine, 2009, v. 15, n. 7, p. 766, doi. 10.1038/nm.1984
- By:
- Publication type:
- Article
Resurrection of a clinical antibody: Template proteogenomic de novo proteomic sequencing and reverse engineering of an anti-lymphotoxin-α antibody.
- Published in:
- Proteomics, 2011, v. 11, n. 3, p. 395, doi. 10.1002/pmic.201000487
- By:
- Publication type:
- Article
An assessment of Motorola CodeLink™ microarray performance for gene expression profiling applications.
- Published in:
- Nucleic Acids Research, 2002, v. 30, n. 7, p. e30, doi. 10.1093/nar/30.7.e30
- By:
- Publication type:
- Article
Dual B Cell Immunotherapy Is Superior to Individual Anti-CD20 Depletion or BAFF Blockade in Murine Models of Spontaneous or Accelerated Lupus.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 1, p. 215, doi. 10.1002/art.38907
- By:
- Publication type:
- Article
First‐in‐human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC‐2394, in healthy volunteers.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 9, p. 1653, doi. 10.1111/cts.13576
- By:
- Publication type:
- Article
Oligodeoxyribonucleotide probe accessibility on a three-dimensional DNA microarray surface and the effect of hybridization time on the accuracy of expression ratios.
- Published in:
- BMC Biotechnology, 2003, v. 3, p. 6, doi. 10.1186/1472-6750-3-6
- By:
- Publication type:
- Article
Quantitative assessment of the use of modified nucleoside triphosphates in expression profiling: differential effects on signal intensities and impacts on expression ratios.
- Published in:
- BMC Biotechnology, 2002, v. 2, p. 14, doi. 10.1186/1472-6750-2-14
- By:
- Publication type:
- Article
In Vivo Assessment of Antibody-Dependent Enhancement of Influenza B Infection.
- Published in:
- Toxicological Sciences, 2019, v. 169, n. 2, p. 409, doi. 10.1093/toxsci/kfz053
- By:
- Publication type:
- Article
Haplotyping the Vitis collinear core genome with rhAmpSeq improves marker transferability in a diverse genus.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-019-14280-1
- By:
- Publication type:
- Article
Resurrection of a clinical antibody: Template proteogenomic de novo proteomic sequencing and reverse engineering of an anti-lymphotoxin-α antibody.
- Published in:
- Proteomics - Clinical Applications, 2011, v. 5, n. 7/8, p. 473, doi. 10.1002/prca.201190049
- By:
- Publication type:
- Article
The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2006, v. 19, n. 7, p. 291, doi. 10.1093/protein/gzl011
- By:
- Publication type:
- Article